Zarator
Hypolipemiant. IHMG-CoA reductase inhibitor. Indicated to treat hypercholesterolemia, dyslipidemias, dysbetalipoproteinemia and for the prevention of more severe cardiovascular events in patients at high cardiovascular risk.
Therapeutic Area
Hypercholesterolemia
Active Ingredient
Atorvastatin
Line
Cardiometabolism + Endocrinology
Pharmaceutical Forms
10 mg coated tablets x 30
10 mg coated tablets x 60
20 mg coated tablets x 30
20 mg coated tablets x 60
40 mg coated tablets x 30
